A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer

Published:2008-10-08 Issue:3 Volume:27 Page:275-279
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Burmeister Bryan H.,Walpole Euan T.,D’Arcy Nancy,Burmeister Elizabeth A.,Cox Sharon,Thomson Damien B.,Harvey Jennifer A.,Smithers B. Mark

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10637-008-9178-4.pdf

Reference14 articles.

1. Coia L, Minsky BD, Berkey BA et al (2000) Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992–1994 patterns of care study. J Clin Oncol 18:455–462

2. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradiotherapy of locally advanced esophageal cancer: long term follow-up of a prospective randomized trial RTOG 85-01. JAMA 281:1623–1627 doi:10.1001/jama.281.17.1623

3. Burmeister BH, Denham JW, O’Brien M et al (1995) Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicentre study. Int J Radiat Oncol Biol Phys 32:997–1006 doi:10.1016/0360-3016(94)00449-U

4. MacKean J, Burmeister BH, Lamb DS et al (1996) Concurrent chemoradiation for oesophageal cancer—factors influencing myelotoxicity. Aust Rad 40:424–429 doi:10.1111/j.1440-1673.1996.tb00440.x

5. Burmeister BH, Walpole ET, Burmeister EA et al (2005) Feasibility of chemoradiation therapy with protracted infusion of 5-fluorouracil for esophageal cancer patients not suitable for cisplatin. Int J Clin Oncol 10:256–261 doi:10.1007/s10147-005-0506-9

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of preoperative concurrent chemoradiotherapy with oxaliplatin for locally advanced esophageal cancer;Journal of the Chinese Medical Association;2017-07

2. Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas;Acta Oncologica;2017-04-04

3. Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint;Autophagy;2016-07-08

4. Cancer of the Esophagus;Clinical Radiation Oncology;2016

5. Volumetric Modulated Arc Therapy vs. c-IMRT for the Treatment of Upper Thoracic Esophageal Cancer;PLOS ONE;2015-03-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3